Encorafenib was approved by FDA recently for
High-Yield Explanation
It is a kinase inhibitor inhibiting thr BRAF gene which is responsible for gene mutations in melanoma
Related Pharmacology MCQs
Which of the following is glucocoicoid synthesis inhibitor?
General
At a high altitude of 3000 m, a person complains of breathlessness. All of the following can...
General
All of the following drugs act on cell membrane except:
General
A non-competitive inhibitor of an enzyme?
General
Which of the following is a phase I metabolic reaction?
General